Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor–Interacting Protein–mutated Pediatric Somatotropinoma

Background: Our objective was to describe the clinical course and treatment challenges in a very young patient with a pituitary adenoma due to a novel aryl hydrocarbon receptor–interacting protein (AIP) gene mutation, highlighting the limitations of somatostatin receptor immunohistochemistry to pred...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Selveta Sanne van Santen, MD, MSc, Adrian F. Daly, MB, BCh, PhD, Michael Buchfelder, MD, PhD, Roland Coras, MD, Yining Zhao, MD, MSc, Albert Beckers, MD, PhD, Aart Jan van der Lely, MD, PhD, Leo J. Hofland, MD, PhD, Rutger K. Balvers, MD, PhD, P. van Koetsveld, Ing, Marry Marrigje van den Heuvel-Eibrink, MD, PhD, Sebastian Johannes Cornelis Martinus Maria Neggers, MD, PhD
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2022-05-01
Colecção:AACE Clinical Case Reports
Assuntos:
acromegaly
gigantism
AIP mutation
pituitary adenoma
macroadenoma
somatotropinoma
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S2376060521001279
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados